take a 23 percent stake in the private biotech company cure back which is working on a coded 1000 baxi now that stake will cost 300000000 europe's your back is based here in germany and is about to begin clinical trials for a coronavirus vaccine later this month here's a closer look at the company that attracting both scientific and political interests. to evacuees one of the big hopes when it comes to developing a vaccine against the corona virus its method is particularly promising now the german government has taken a 20 percent stake in the company giving it a 300000000 euros boost. these are the 5 this investment is a way of providing back with security so that it can continue to work with commitment towards producing a vaccine. cure back hit the headlines this year when the us government allegedly attempted to entice the company over to america monday's move is therefore also about sending a clear message about the government's industrial policy. doesn't really want high tech businesses companies which serves people to continue to develop their products in germany and europe and